Mycotoxin adducts on human serum albumin: Biomarkers of exposure to Stachybotrys chartarum

Environmental Health Perspectives

Volumn 114, Issue 8, 2006, Pages 1221-1226

  Yike, Iwona ^a   Distler, Anne M ^b   Ziady, Assem G ^a   Dearborn, Dorr G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Satratoxin G.; Stachybotrys chartarum; Trichothecenes

Indexed keywords

AMINO ACID; AMINOPEPTIDASE; BIOLOGICAL MARKER; CYSTEINE; FUNGUS ANTIBODY; HISTIDINE; HUMAN SERUM ALBUMIN; LYSINE; MYCOTOXIN; PEPTIDE DERIVATIVE; PRONASE; SATRATOXIN G; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGUS SPORE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MASS SPECTROMETRY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION; RAT; STACHYBOTRYS CHARTARUM; WESTERN BLOTTING;

AMINO ACID SEQUENCE; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYDROLYSIS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MYCOTOXINS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SPORES, FUNGAL; STACHYBOTRYS; TRICHOTHECENES; TRYPSIN;

ANIMALIA; FUNGI; STACHYBOTRYS CHARTARUM;

EID: 33746929928     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9064     Document Type: Article

References (31)

1. Andersen B, Nielsen KF, Jarvis BB. 2002. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia 94:392-403.
2. Biemann, K. 1990. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol 193:886-887.
3. Brasel TL, Campbell AW, Demers RE, Ferguson BS, Fink J, Vojdani A, et al. 2004. Detection of trichothecene mycotoxins in sera from individuals exposed to Stachybotrys chartarum in indoor environments. Arch Environ Health 59:317-323.
4. Chung YJ, Jarvis BB, Tak H, Pestka JJ. 2003. Immunochemical assay for satratoxin G and other macrocylcic trichothecenes associated with indoor air contaminination by Stachybotrys chartarum. Toxicol Mech Methods 13:1-7.
5. Croft WA, Jarvis BB, Yatawara CS. 1986. Airborne outbreak of trichothecene toxicosis. Atmos Environ 20:549-552.
6. Dearborn DG, Dahms BB, Allan TM, Sorenson WG, Montana E, Etzel RA. 2002. Clinical profile of 30 infants with acute pulmonary hemorrhage in Cleveland. Pediatrics 110:627-637.
7. Dearborn DG, Yike I, Miller MJ, Etzel RA. 1999. An overview of the investigation into pulmonary hemorrhage in infants in Cleveland, Ohio. Environ Health Perspect 107(suppl 3):495-499.
8. Dillon HK, Miller JD, Sorenson WG, Douwes J, Jacobs RR. 1999. Review of methods applicable to the assessment of mold exposure to children. Environ Health Perspect 107(suppl 3): 473-480.
9. Etzel RA. 2003. Stachybotrys. Curr Opin Pediatr 15:103-106.
10. Etzel RA, Montana E, Sorenson WG, Kullman J, Allan TM, Dearborn DG. 1998. Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 152:757-762.
11. Feinberg B, MacLaughlin CS. 1989. Biochemical mechanism of action of trichothecene mycotoxins. In: Trichothecene Mycotoxins: Pathophysiologic Effects (Beasley VR, ed). Vol 1. Boca Raton, FLCRC Press, 27-36.
12. Gregory L, Pestka J, Dearborn D, Rand TG. 2004. Localization of satratoxin-G in Stachybotrys chartarum spores and spore impacted mouse lung using immunocytochemistry. Toxicol Pathol 32:26-34.
13. Groopman JD, Kensler TW. 1999. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis 20:1-11.
14. Guengerich FP, Arneson KO, Williams KM, Deng Z, Harris TM. 2002. Reaction of aflatoxin B1 oxidation products with lysine. Chem Res Toxicol 15:780-792.
15. Haugland RA, Vesper SJ, Wymer LJ. 1999. Quantitative measurement of Stachybotrys chartarum conidia using real time detection of PCR products with the TaqMan™ fluorogenic probe system. Mol Cell Probes 13:329-340.
16. Hodgson MJ, Morey P, Wing-Yan L, Morrow L, Miller D, Jarvis BB, et al. 1998. Building associated pulmonary disease from exposure to Stachybotrys chartarum, and Aspergillus versicolor. J Occup Environ Med 40:241-249.
17. Horner WE. 2005. The damp building effect: understanding needed, not more debate. Ann Allergy Asthma Immunol 94:213-215.
18. Hossain MA, Ahmed MS, Ghannoum MA. 2004. Attributes of Stachybotrys chartarum and its association with human disease. J Allergy Clin Immunol 113:200-208.
19. Jarvis BB, Sorenson WG, Hintikka E-L, Nikulin M, Zhou Y, Yang J, et al. 1998. Study of toxin production by isolates of Stachybotrys chartarum and Memnoniella echinata isolated during a study of pulmonary hemosiderosis in infants. Appl Environ Microbiol 64:3620-3625.
20. Johanning E, Biagini R, Hull D, Morey P, Jarvis B, Landsbergis P. 1996. Health and immunology study following exposure to toxigenic fungi (Stachybotrys chartarum) in a water-damaged office environment. Int Arch Occup Environ Health 68:207-218
21. Leino M, Makela M, Reijula T, Haathela T, Mussalo-Rauhamaa H, Hintikka E-L, et al. 2003. Intranasal exposure to a damp building mold, Stachybotrys chartarum, induces lung inflammation in mice by satratoxin independent mechanisms. Clin Exp Allergy 33:1603-1610.
22. Miller JD, Rand TG, Jarvis BB. 2003. Stachybotrys chartarum: a really malicious mold. Med Mycol 41:271-291.
23. Montana E, Etzel RA, Allan TM, Horgan TE, Dearborn DG. 1997. Environmental risk factors associated with pediatric idiopathic pulmonary hemosiderosis in a Cleveland community. Pediatrics 99(1):e5. Available: http://www.pediatrics.org/cgi/content/full/99/1/e5[accessed 04/11/06].
24. Sabbioni G, Ambs S, Wagon GN, Groopman JD. 1990. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis 11:2063-2066.
25. Schmechel D, Simpson JP, Beezhold D, Lewis DM. 2006. The development of species-specific immunodiagnostics for Stachybotrys chartarum: the role of cross-reactivity. J Immunol Methods 309:150-159.
26. Swanson SP, Corley RA, 1989. The distribution, metabolism, and excretion of trichothecene mycotoxins. In: Trichothecene Mycotoxins: Pathophysiologic Effects (Beasley VR, ed). Vol I. Boca Raton, FLCRC Press, 37-62.
27. Van Emon JM, Reed AW, Yike I, Vesper SJ. 2003. Measurement of Stachylysin™ in serum to quantify human exposures to the indoor mold Stachybotrys chartarum. J Occup Environ Med 45:582-591.
28. Vesper SJ, Dearborn DG, Yike I, Sorenson WG, Haugland RA. 1999. Hemolysis, toxicity and RAPD analysis of Stachybotrys chartarum strains from the Cleveland pulmonary hemorrhage outbreak and non-Cleveland strains. Appl Environ Microbiol 65:3175-3181.
29. Vesper SJ, Magnuson S, Dearborn D, Yike I, Haugland RA. 2001. Initial characterization of the hemolysin from Stachybotrys chartarum. Infect Immun 69:912-916.
30. Yike I, Dearborn DG. 2004. Pulmonary effects of Stachybotrys chartarum in animal studies. Adv Appl Microbiol 55:241-273.
31. Yike I, Rand T, Dearborn DG. 2005. Acute inflammatory responses to Stachybotrys chartarum in the lungs of infant rats: time course and possible mechanisms. Toxicol Sci 84:408-417.